Michael Pan

Michael Pan practices at South Pacific Surgery Center in Beverly Hills, California.

Michael Pan's NPI, 1144607680, was assigned on May 5, 2015. Michael Pan graduated from Icahn School Of Medicine At Mount Sinai in 2015. Michael Pan holds California license A161456.

Michael Pan's primary practice is South Pacific Surgery Center, at 99 La Cienega Boulevard Suite 102, Beverly Hills, CA 90211. The practice phone is (310) 360-7368.

Michael Pan's primary practice is South Pacific Surgery Center in Beverly Hills, California. Michael Pan is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Michael Pan to 2 more group practices and clinics, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Pan practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Michael Pan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Michael Pan is board certified in dermatology by the American Board of Dermatology. Michael Pan is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, scalp rash and skin cyst among the conditions Michael Pan treats.

CMS data shows 586 Medicare services from Michael Pan across 11 procedure codes in 2024, for 222 Medicare patients. Medicare paid $40,191 for them. Every service was in an office.

CMS counts 222 Medicare patients who saw Michael Pan in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Pan's median patient age at 49, with 59% women.

In 2024, Michael Pan wrote 463 Medicare Part D claims for 201 patients. 98% of them were for generic drugs. CMS names the drug for 355 of them, across 12 drugs with 11 or more claims each, at $8,656 in total drug cost. In 2023, CMS named 167 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Michael Pan for performance year 2024, reported as part of a group. Michael Pan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Pan as offering telehealth. CMS counts 173 procedures of removal of skin lesions by Michael Pan, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Michael Pan, published from 2013 to 2014. 2014 was the busiest year, with 2. The most frequent topics are Melanoma and Skin Neoplasms. Michael Pan's most frequent co-authors are Jacob Levitt, MD, Sebastian Gordon Bernardo, MD and Lauren Elizabeth Geller, MD.

CMS Open Payments shows 62 general payments to Michael Pan from 14 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $1,110.

Michael Pan graduated from Icahn School Of Medicine At Mount Sinai in 2015.

Michael Pan is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.